Homzhans is a leading platform and a health tech company that aims to transform healthcare and research by using digital-first solutions. Homzhans offers three main products: Hospital at Home (RPM), Decentralized Clinical Trials (DCT), and Companion Apps (SaMD).

  • Hospital at Home and Remote Patients Monitoring (RPM) is a technology that collects real-world patient data remotely and connects patients and clinical teams. It enables greater access to care from any location and improves efficiency for clinicians.
  • Decentralized Clinical Trials (DCT) is a platform that enables remote recruitment, consent, and monitoring of participants in clinical trials. It reduces the burden and cost of traditional trials and accelerates the development of new therapies.
  • Companion Apps (SaMD) are software applications that provide medical diagnosis, treatment, or support. They are designed to work with medical devices, wearables, or sensors, and can help patients manage their conditions and improve their outcomes.

Software as a Medical Device. It refers to software that is intended to be used for one or more medical purposes without being part of a hardware medical device. In other words,
SaMD performs medical functions on its own, without relying on physical hardware components. This category of software plays a crucial role in modern healthcare, as technology continues to advance and digital platforms become integral to both medical and non-medical purposes.SaMD contributes to improved patient care, remote monitoring, and decentralized clinical trials, making it a vital component in the evolving landscape of healthcare technology.
Homzhans collaborates with various partners, such as Shahid Beheshti University , Ministry of Health and Medical Education, and international health Organizations, to advance its vision of longer, fuller lives with digital-first care and research.